{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:27:06Z","timestamp":1792722426085,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81602667"],"award-info":[{"award-number":["81602667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515220015"],"award-info":[{"award-number":["2023A1515220015"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["A2015534"],"award-info":[{"award-number":["A2015534"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["B2023390"],"award-info":[{"award-number":["B2023390"]}]},{"name":"Shantou Medical and Health Science and Technology Planning Project","award":["[2022] 88-7"],"award-info":[{"award-number":["[2022] 88-7"]}]},{"name":"Shantou Medical and Health Science and Technology Planning Project","award":["[2022] 81-1"],"award-info":[{"award-number":["[2022] 81-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-64352-8","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T19:34:09Z","timestamp":1785958449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical-radiomic model development for local recurrence prediction in stereotactic body radiation therapy-treated lung cancer: comparative analysis with radiobiological models"],"prefix":"10.1038","volume":"16","author":[{"given":"Bao-Tian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Xian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Mei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"64352_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter, A. et al. The global burden of lung cancer: Current status and future trends. Nat. Rev. Clin. Oncol. 20, 624\u2013639 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"64352_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jtho.2021.04.002","volume":"16","author":"N Andruska","year":"2021","unstructured":"Andruska, N. et al. Stereotactic radiation for lung cancer: A practical approach to challenging scenarios. J. Thorac. Oncol. 16, 1075\u20131085 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"64352_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","volume":"88","author":"JM Brown","year":"2014","unstructured":"Brown, J. M. et al. The tumor radiobiology of SRS and SBRT: Are more than the 5 Rs involved?. Int. J. Radiat. Oncol. *Biol. *Phys. 88, 254\u2013262 (2014).","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"64352_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jtho.2019.08.2505","volume":"15","author":"AC Moreno","year":"2020","unstructured":"Moreno, A. C. et al. Biologically effective dose in stereotactic body radiotherapy and survival for patients with early-stage NSCLC. J. Thorac. Oncol. 15, 101\u2013109 (2020).","journal-title":"J. Thorac. Oncol."},{"key":"64352_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijrobp.2021.11.027","volume":"113","author":"K Lee","year":"2022","unstructured":"Lee, K. et al. A systematic review into the radiologic features predicting local recurrence after stereotactic ablative body radiotherapy (SABR) in patients with non-small cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 113, 40\u201359 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"64352_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108978","volume":"127","author":"T-H Kim","year":"2020","unstructured":"Kim, T.-H. et al. Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis. Eur. J. Radiol. 127, 108978 (2020).","journal-title":"Eur. J. Radiol."},{"key":"64352_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jtho.2019.10.016","volume":"15","author":"ED Brooks","year":"2020","unstructured":"Brooks, E. D. et al. Salvage therapy for locoregional recurrence after stereotactic ablative radiotherapy for early-stage NSCLC. J. Thorac. Oncol. 15, 176\u2013189 (2020).","journal-title":"J. Thorac. Oncol."},{"key":"64352_CR8","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","volume":"2","author":"H Onishi","year":"2007","unstructured":"Onishi, H. et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J. Thorac. Oncol. 2, S94-100 (2007).","journal-title":"J. Thorac. Oncol."},{"key":"64352_CR9","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.prro.2017.10.002","volume":"8","author":"N Ohri","year":"2018","unstructured":"Ohri, N. et al. Stereotactic body radiation therapy for stage I non-small cell lung cancer: The importance of treatment planning algorithm and evaluation of a tumor control probability model. Pract. Radiat. Oncol. 8, e33\u2013e39 (2018).","journal-title":"Pract. Radiat. Oncol."},{"key":"64352_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijrobp.2020.03.005","volume":"107","author":"RJ Klement","year":"2020","unstructured":"Klement, R. J. et al. Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: A modeling study on 1500 individual treatments. Int. J. Radiat. Oncol. Biol. Phys. 107, 579\u2013586 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"64352_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2016.11.006","volume":"122","author":"F Liu","year":"2017","unstructured":"Liu, F. et al. Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. Radiother. Oncol. 122, 286\u2013294 (2017).","journal-title":"Radiother. Oncol."},{"key":"64352_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13014-016-0643-5","volume":"11","author":"A Santiago","year":"2016","unstructured":"Santiago, A. et al. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?. Radiat. Oncol. 11, 67 (2016).","journal-title":"Radiat. Oncol."},{"key":"64352_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2013.09.005","volume":"109","author":"M Guckenberger","year":"2013","unstructured":"Guckenberger, M. et al. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother. Oncol. 109, 13\u201320 (2013).","journal-title":"Radiother. Oncol."},{"key":"64352_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ijrobp.2015.12.004","volume":"94","author":"RJ Klement","year":"2016","unstructured":"Klement, R. J. et al. Bayesian cure rate modeling of local tumor control: Evaluation in stereotactic body radiation therapy for pulmonary metastases. Int. J. Radiat. Oncol. Biol. Phys. 94, 841\u2013849 (2016).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"64352_CR15","doi-asserted-by":"publisher","first-page":"1431140","DOI":"10.3389\/fonc.2024.1431140","volume":"14","author":"BT Huang","year":"2024","unstructured":"Huang, B. T. et al. External validation of radiobiological models for local control prediction in lung cancer patients treated with stereotactic body radiation therapy. Front Oncol. 14, 1431140 (2024).","journal-title":"Front Oncol."},{"key":"64352_CR16","doi-asserted-by":"publisher","first-page":"025007","DOI":"10.1088\/1361-6560\/aaf5a5","volume":"64","author":"KJ Lafata","year":"2019","unstructured":"Lafata, K. J. et al. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy. Phys. Med. Biol. 64, 025007 (2019).","journal-title":"Phys. Med. Biol."},{"key":"64352_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.819047","volume":"11","author":"LM Luo","year":"2021","unstructured":"Luo, L. M. et al. A combined model to improve the prediction of local control for lung cancer patients undergoing stereotactic body radiotherapy based on radiomic signature plus clinical and dosimetric parameters. Front. Oncol. 11, 819047 (2021).","journal-title":"Front. Oncol."},{"key":"64352_CR18","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.21873\/anticanres.16699","volume":"43","author":"Y Isoyama-Shirakawa","year":"2023","unstructured":"Isoyama-Shirakawa, Y. et al. Combination of clinical factors and radiomics can predict local recurrence and metastasis after stereotactic body radiotherapy for non-small cell lung cancer. Anticancer Res. 43, 5003\u20135013 (2023).","journal-title":"Anticancer Res."},{"key":"64352_CR19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00259-023-06510-y","volume":"51","author":"F Lucia","year":"2024","unstructured":"Lucia, F. et al. Multicentric development and evaluation of [18F]FDG PET\/CT and CT radiomic models to predict regional and\/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy. Eur. J. Nucl. Med. Mol. Imaging. 51, 1097\u20131108 (2024).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"64352_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.ijrobp.2024.06.010","volume":"120","author":"J Ni","year":"2024","unstructured":"Ni, J. et al. Predicting regional recurrence and prognosis in stereotactic body radiation therapy-treated clinical stage I non-small cell lung cancer using a radiomics model constructed with surgical data. Int. J. Radiat. Oncol. Biol. Phys. 120, 1096\u20131106 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"64352_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/JCO.2017.74.9671","volume":"36","author":"BJ Schneider","year":"2018","unstructured":"Schneider, B. J. et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline. J. Clin. Oncol. 36, 710\u2013719 (2018).","journal-title":"J. Clin. Oncol."},{"key":"64352_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2019.01.035","volume":"134","author":"A Lenglet","year":"2019","unstructured":"Lenglet, A. et al. Risk-adapted stereotactic ablative radiotherapy for central and ultra-central lung tumours. Radiother. Oncol. 134, 178\u2013184 (2019).","journal-title":"Radiother. Oncol."},{"key":"64352_CR23","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1016\/j.ijrobp.2012.04.040","volume":"84","author":"N Ohri","year":"2012","unstructured":"Ohri, N. et al. Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: A report from the elekta collaborative lung research group. Int. J. Radiat. Oncol. Biol. Phys. 84, e379-384 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"64352_CR24","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen, J. J. M. et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77, e104\u2013e107 (2017).","journal-title":"Cancer Res."},{"key":"64352_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg, A. et al. The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295, 328\u2013338 (2020).","journal-title":"Radiology"},{"key":"64352_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05536-x","volume":"150","author":"BT Huang","year":"2024","unstructured":"Huang, B. T. et al. Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy. J. Cancer Res. Clin. Oncol. 150, 34 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"64352_CR27","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/j.cllc.2023.08.007","volume":"24","author":"BT Huang","year":"2023","unstructured":"Huang, B. T. et al. Developing a prediction model for radiation pneumonitis in lung cancer patients treated with stereotactic body radiation therapy combined with clinical, dosimetric factors, and laboratory biomarkers. Clin. Lung Cancer 24, e323-e331.e2 (2023).","journal-title":"Clin. Lung Cancer"},{"key":"64352_CR28","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/0013164418817803","volume":"79","author":"KM Marcoulides","year":"2019","unstructured":"Marcoulides, K. M. & Raykov, T. Evaluation of variance inflation factors in regression models using latent variable modeling methods. Educ. Psychol. Meas. 79, 874\u2013882 (2019).","journal-title":"Educ. Psychol. Meas."},{"key":"64352_CR29","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2967\/jnumed.119.228106","volume":"61","author":"G Dissaux","year":"2020","unstructured":"Dissaux, G. et al. Pretreatment 18F-FDG PET\/CT radiomics predict local recurrence in patients treated with stereotactic body radiotherapy for early-stage non-small cell lung cancer: A multicentric study. J. Nucl. Med. 61, 814\u2013820 (2020).","journal-title":"J. Nucl. Med."},{"key":"64352_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.967360","volume":"12","author":"H Yang","year":"2022","unstructured":"Yang, H. et al. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. Front. Oncol. 12, 967360 (2022).","journal-title":"Front. Oncol."},{"key":"64352_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.radonc.2020.02.005","volume":"146","author":"TT Zhai","year":"2020","unstructured":"Zhai, T. T. et al. Pre-treatment radiomic features predict individual lymph node failure for head and neck cancer patients. Radiother. Oncol. 146, 58\u201365 (2020).","journal-title":"Radiother. Oncol."},{"key":"64352_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.radonc.2017.07.013","volume":"124","author":"TT Zhai","year":"2017","unstructured":"Zhai, T. T. et al. Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters. Radiother. Oncol. 124, 256\u2013262 (2017).","journal-title":"Radiother. Oncol."},{"key":"64352_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ijrobp.2021.01.042","volume":"110","author":"S Cui","year":"2021","unstructured":"Cui, S. et al. Integrating multiomics information in deep learning architectures for joint actuarial outcome prediction in non-small cell lung cancer patients after radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 110, 893\u2013904 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"64352_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1148\/radiol.2018172361","volume":"288","author":"R Berenguer","year":"2018","unstructured":"Berenguer, R. et al. Radiomics of CT features may be nonreproducible and redundant: Influence of CT acquisition parameters. Radiology 288, 407\u2013415 (2018).","journal-title":"Radiology"},{"key":"64352_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1148\/radiol.2019190928","volume":"293","author":"M Meyer","year":"2019","unstructured":"Meyer, M. et al. Reproducibility of CT radiomic features within the same patient: Influence of radiation dose and CT reconstruction settings. Radiology 293, 583\u2013591 (2019).","journal-title":"Radiology"},{"key":"64352_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.radonc.2015.09.008","volume":"118","author":"M Guckenberger","year":"2016","unstructured":"Guckenberger, M. et al. Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother. Oncol. 118, 485\u2013491 (2016).","journal-title":"Radiother. Oncol."},{"key":"64352_CR37","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/JTO.0000000000000484","volume":"10","author":"HS Park","year":"2015","unstructured":"Park, H. S. et al. Central versus peripheral tumor location: Influence on survival, local control, and toxicity following stereotactic body radiotherapy for primary non-small-cell lung cancer. J. Thorac. Oncol. 10, 832\u2013837 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"64352_CR38","unstructured":"PyRadiomics Community. PyRadiomics documentation. Available at: https:\/\/pyradiomics.readthedocs.io\/en\/latest\/index.html [Accessed September 28, 2025] (2016)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64352-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64352-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64352-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:20:00Z","timestamp":1787584800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64352-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["64352"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-64352-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26516"}}